Odyssey Therapeutics Ownership | Who Owns Odyssey Therapeutics?
Odyssey Therapeutics Ownership Summary
Odyssey Therapeutics is owned by 74.02% institutional investors, 6.07% insiders, and 19.91% retail investors. Fmr is the largest institutional shareholder, holding 20.61% of ODTX shares. Fidelity Growth Company Fund is the top mutual fund, with 2.30% of its assets in Odyssey Therapeutics shares.
ODTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Odyssey Therapeutics | 74.02% | 6.07% | 19.91% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 6.24M | 20.61% | $135.84M |
| Lightspeed management | 3.61M | 11.92% | $80.18M |
| Sr one capital management, lp | 3.79M | 8.04% | $71.00M |
| Tpg gp a | 3.69M | 7.82% | $69.04M |
| Sanofi | 1.99M | 6.57% | $44.22M |
| Orbimed advisors | 3.00M | 6.36% | $56.15M |
| Affinity asset advisors | 1.26M | 4.16% | $28.00M |
| Blackrock funding, inc. /de | 1.14M | 3.78% | $25.42M |
| Sands capital ventures | 875.00K | 2.89% | $19.44M |
| Vanguard capital management | 734.31K | 2.43% | $16.32M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| General catalyst group management | 810.27K | 8.04% | $15.16M |
| Sanofi | 1.99M | 7.02% | $44.22M |
| Sr one capital management, lp | 3.79M | 6.83% | $71.00M |
| Lightspeed management | 3.61M | 3.95% | $80.18M |
| Foresite capital management v | 713.11K | 3.68% | $13.34M |
| Sands capital ventures | 875.00K | 2.80% | $19.44M |
| Hhlr advisors | 831.66K | 1.87% | $15.56M |
| Catalio capital management, lp | 457.84K | 1.61% | $8.57M |
| Vivo capital | 575.00K | 1.41% | $12.78M |
| Tpg gp a | 3.69M | 1.38% | $69.04M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Sr one capital management, lp | 3.79M | 6.83% | 3.79M |
| Tpg gp a | 3.69M | 1.38% | 3.69M |
| Orbimed advisors | 3.00M | 1.05% | 3.00M |
| Fmr | 6.24M | 0.01% | 1.06M |
| Deerfield management company, l.p. (series c) | 1.05M | 0.20% | 1.05M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Marshall wace, llp | 297.04K | 0.01% | -195.66K |
| Sixth street partners management company | - | - | -101.53K |
| Ubs group | 1.42K | - | -67.34K |
| Hudson bay capital management lp | 30.00K | 0.00% | -42.92K |
| Jpmorgan chase | 8.15K | - | -19.64K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sr one capital management, lp | 3.79M | 6.83% | 3.79M | $71.00M |
| Tpg gp a | 3.69M | 1.38% | 3.69M | $69.04M |
| Orbimed advisors | 3.00M | 1.05% | 3.00M | $56.15M |
| Deerfield management company, l.p. (series c) | 1.05M | 0.20% | 1.05M | $19.57M |
| Hhlr advisors | 831.66K | 1.87% | 831.66K | $15.56M |
Sold Out
| Holder | Change |
|---|---|
| Sixth street partners management company | -101.53K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 59 | - | 34,916,655 | - | 74 | - | 59 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Company Fund | 1.10M | 2.30% | 70.80K |
| Fidelity Growth Compy Commingled Pl S | 1.08M | 2.25% | 281.40K |
| Vanguard Morn Total Stk Mkt Idx Investor | 531.10K | 1.11% | 448.20K |
| Vanguard MStar Total Stk Mkt Idx Invest | 531.10K | 1.11% | - |
| HBM Healthcare Investments AG Ord | 507.81K | 1.06% | - |
| iShares Russell 2000 ETF | 413.28K | 0.86% | - |
| T. Rowe Price Health Sciences | 373.04K | 0.78% | - |
| Fidelity Select Biotechnology | 340.70K | 0.71% | 1.20K |
| Fidelity Growth Company K6 | 308.86K | 0.64% | 20.20K |
| Fidelity Series Growth Company | 266.60K | 0.55% | 17.50K |
ODTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools